ROSENNY CHASIN: Open Payments
NPI 1407222599 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,265 in 44 payments from 15 companies in 2025. Trend: 2023 $19 · 2024 $599 · 2025 $1,265
Food & beverage: $1,180Education: $85
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $294 |
| Janssen Biotech, Inc. | 13 | $227 |
| Galderma Laboratories, L.P. | 3 | $152 |
| GENZYME CORPORATION | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 2 | $111 |
| Exact Sciences Corporation | 3 | $65 |
| Amgen Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Organon LLC | 6 | $39 |
| Lilly USA, LLC | 2 | $29 |
Products named: OPZELURA, DUPIXENT, TREMFYA, NEMLUVIO, Cologuard Collection Kit, OTEZLA, Auvelity, MOUNJARO.
Industry payments across NY — which companies pay providers there.
